JP2008509137A5 - - Google Patents

Download PDF

Info

Publication number
JP2008509137A5
JP2008509137A5 JP2007524823A JP2007524823A JP2008509137A5 JP 2008509137 A5 JP2008509137 A5 JP 2008509137A5 JP 2007524823 A JP2007524823 A JP 2007524823A JP 2007524823 A JP2007524823 A JP 2007524823A JP 2008509137 A5 JP2008509137 A5 JP 2008509137A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
alkyl
group
composition according
phenyl moiety
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007524823A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008509137A (ja
JP5039550B2 (ja
Filing date
Publication date
Priority claimed from US10/912,948 external-priority patent/US7928132B2/en
Application filed filed Critical
Publication of JP2008509137A publication Critical patent/JP2008509137A/ja
Publication of JP2008509137A5 publication Critical patent/JP2008509137A5/ja
Application granted granted Critical
Publication of JP5039550B2 publication Critical patent/JP5039550B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007524823A 2004-08-06 2005-07-14 大腸炎の治療のための組成物及び方法 Expired - Fee Related JP5039550B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/912,948 US7928132B2 (en) 2004-08-06 2004-08-06 Methods for the amelioration of episodes of acute or chronic ulcerative colitis
US10/912,948 2004-08-06
PCT/US2005/025067 WO2006019962A1 (en) 2004-08-06 2005-07-14 Compositions and methods for treatment of colitis

Publications (3)

Publication Number Publication Date
JP2008509137A JP2008509137A (ja) 2008-03-27
JP2008509137A5 true JP2008509137A5 (cg-RX-API-DMAC7.html) 2008-09-04
JP5039550B2 JP5039550B2 (ja) 2012-10-03

Family

ID=35355847

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007524823A Expired - Fee Related JP5039550B2 (ja) 2004-08-06 2005-07-14 大腸炎の治療のための組成物及び方法

Country Status (6)

Country Link
US (1) US7928132B2 (cg-RX-API-DMAC7.html)
EP (1) EP1773329A1 (cg-RX-API-DMAC7.html)
JP (1) JP5039550B2 (cg-RX-API-DMAC7.html)
AU (1) AU2005275023B2 (cg-RX-API-DMAC7.html)
CA (1) CA2575777C (cg-RX-API-DMAC7.html)
WO (1) WO2006019962A1 (cg-RX-API-DMAC7.html)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1664796B1 (en) * 2003-09-15 2010-12-15 Oklahoma Medical Research Foundation Method of using cytokine assays to diagnose, treat, and evaluate ankylosing spondylitis
US20060211752A1 (en) * 2004-03-16 2006-09-21 Kohn Leonard D Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression
US7943328B1 (en) 2006-03-03 2011-05-17 Prometheus Laboratories Inc. Method and system for assisting in diagnosing irritable bowel syndrome
US20080085524A1 (en) 2006-08-15 2008-04-10 Prometheus Laboratories Inc. Methods for diagnosing irritable bowel syndrome
FR2917087B1 (fr) 2007-06-05 2012-09-21 Galderma Res & Dev Nouveaux 4-phenyl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique.
US20090215908A1 (en) * 2007-09-24 2009-08-27 Reliance Life Sciences Pvt. Ltd. Toll like receptor (tlr) signaling antagonist
ES2569608T3 (es) 2008-04-09 2016-05-11 The University Of North Carolina At Chapel Hill Procedimientos de regulación del reordenamiento del citoesqueleto de actina y formación de espacios intercelulares
MX2011010616A (es) * 2009-04-09 2012-03-14 Univ North Carolina Metodos para tratar edema relacionado a isquemia-reperfusion.
WO2010127367A2 (en) 2009-05-01 2010-11-04 Alfagene Bioscience, Inc. Human gastrointestinal stem cell-derived primary intestinal epithelial cell system and methods of use thereof
US10668092B2 (en) 2010-09-24 2020-06-02 The John Hopkins University Compositions and methods for treatment of inflammatory disorders
US9422262B2 (en) * 2010-09-24 2016-08-23 The Broad Institute, Inc. Compounds and methods for treating diseases mediated by protease activated receptors
KR101213070B1 (ko) 2010-11-09 2012-12-18 부산대학교 산학협력단 포스포리파아제 d1억제제를 유효성분으로 포함하는 류마티스 관절염 예방 또는 치료용 조성물
AU2013232733B2 (en) 2012-03-13 2017-01-19 James Cook University Method for treating inflammation
US8865723B2 (en) 2012-10-25 2014-10-21 Tetra Discovery Partners Llc Selective PDE4 B inhibition and improvement in cognition in subjects with brain injury
US20140271666A1 (en) * 2013-03-14 2014-09-18 Immune Pharmaceuticals Ltd. Use of anti-eotaxin antibodies for treating inflammatory bowel disease
CN105745223A (zh) 2013-09-18 2016-07-06 詹姆斯库克大学 修饰的抗炎蛋白及使用方法
WO2015066490A1 (en) 2013-10-31 2015-05-07 Ohio University Prevention and treatment of non-alcoholic fatty liver disease
CA2955582C (en) 2014-07-18 2021-03-16 Ohio University Imidazole and thiazole compositions for modifying biological signaling
CN105486869A (zh) * 2014-10-08 2016-04-13 江苏维赛科技生物发展有限公司 一种检测动物源食品中甲巯咪唑残留的酶联免疫试剂盒及其应用
KR101647918B1 (ko) * 2015-03-09 2016-08-11 성균관대학교산학협력단 포스포리파제 d2 억제제를 유효성분으로 포함하는 박테리아 감염 질환 예방 또는 치료용 조성물
CN111936127A (zh) 2018-02-15 2020-11-13 国立大学法人千叶大学 炎症性疾病或骨病的预防或治疗剂及医药组合物
EP4081201A4 (en) * 2019-12-24 2024-01-10 Aardvark Therapeutics Inc. PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF MANY INFLAMMATORY DISORDERS
CN113730444A (zh) * 2021-07-27 2021-12-03 自然资源部第一海洋研究所 一种海带中可溶性膳食纤维在制备用于改善溃疡性结肠炎的药物和功能性食品中的应用
CN114288388B (zh) * 2022-01-25 2023-11-03 华中科技大学同济医学院附属协和医院 网膜素在制备炎症性肠病治疗药物中的应用
CN114903883A (zh) * 2022-05-19 2022-08-16 南华大学附属第一医院 甜菜碱在制备治疗溃疡性结肠炎的药物中的用途
CN116473966B (zh) * 2023-03-29 2025-06-13 广州医科大学 Sb-222200在抑制nlrp3炎症小体活化中的应用
CN119174731B (zh) * 2024-11-15 2025-03-14 温州医科大学附属口腔医院 一种pmc纳米酶及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536809A (en) * 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3630200A (en) * 1969-06-09 1971-12-28 Alza Corp Ocular insert
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4008719A (en) * 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
US4734421A (en) * 1986-10-29 1988-03-29 Merck & Co., Inc. Anti-inflammatory substituted 2-benzyl-mercapto-imidazole and pyrimidine derivatives compositions and method of use therefor
US5480583A (en) * 1991-12-02 1996-01-02 Intevep, S.A. Emulsion of viscous hydrocarbon in aqueous buffer solution and method for preparing same
US6365616B1 (en) * 1998-08-31 2002-04-02 Sentron Medical, Inc. Methimazole derivatives and tautomeric cyclic thiones to treat autoimmune diseases
DE19850445A1 (de) * 1998-11-02 2000-05-04 Falk Pharma Gmbh Arzneimittel zur topischen Behandlung entzündlicher Darmerkrankungen
EA008150B1 (ru) * 2002-08-26 2007-04-27 С. Л. А. Фарма Аг Фармацевтическая композиция
US20050209295A1 (en) * 2004-03-16 2005-09-22 Kohn Leonard D Methimazole derivatives and tautomeric cyclic thiones to inhibit cell adhesion
CA2559712A1 (en) * 2004-03-16 2005-10-13 Interthyr Corporation Methimazole derivatives and tautomeric cyclic thiones to inhibit cell adhesion

Similar Documents

Publication Publication Date Title
JP2008509137A5 (cg-RX-API-DMAC7.html)
KR101585848B1 (ko) 관절염의 치료 방법
JP2018517686A5 (cg-RX-API-DMAC7.html)
JP2004501930A5 (cg-RX-API-DMAC7.html)
JP2011507878A5 (cg-RX-API-DMAC7.html)
TWI598098B (zh) 脂質異常症治療劑
JP5039550B2 (ja) 大腸炎の治療のための組成物及び方法
JP2018188478A (ja) 肝疾患を処置する方法
BRPI0513843A (pt) composto ou um sal ou solvato ou uma pró-droga farmaceuticamente aceitável do mesmo, composição farmacêutica, forma de dosagem, uso de um composto, e, sal de cloridrato
JP2009521399A5 (cg-RX-API-DMAC7.html)
JP2009507896A5 (cg-RX-API-DMAC7.html)
JP2006524660A5 (cg-RX-API-DMAC7.html)
JP2021054868A (ja) がんの処置のための併用療法
JP2011507879A5 (cg-RX-API-DMAC7.html)
JP2012515787A5 (cg-RX-API-DMAC7.html)
RU2015143843A (ru) Ингибиторы гистондеацетилазы
JP2008533151A5 (cg-RX-API-DMAC7.html)
JP2006517939A5 (cg-RX-API-DMAC7.html)
JP2007530601A5 (cg-RX-API-DMAC7.html)
JP2012515788A5 (cg-RX-API-DMAC7.html)
CN1121690A (zh) 噻唑烷二酮在治疗动脉粥样硬化和摄食性疾病方面的用途
JP2009541387A5 (cg-RX-API-DMAC7.html)
RU2329254C2 (ru) Производные бензимидазола, композиции, содержащие их, их получение и их применение
JP2019531356A5 (cg-RX-API-DMAC7.html)
JP2009501746A5 (cg-RX-API-DMAC7.html)